EE+ POEM Archive
Ticagrelor no more effective and less well-tolerated than clopidogrel in patients with PAD (EUCLID trial)
Ticagrelor no more effective and less well-tolerated than clopidogrel in patients with PAD (EUCLID trial) is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Ticagrelor No More Effective and Less Well-tolerated Than Clopidogrel in Patients With PAD (EUCLID Trial)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314204/all/Ticagrelor_no_more_effective_and_less_well_tolerated_than_clopidogrel_in_patients_with_PAD__EUCLID_trial_.
Ticagrelor no more effective and less well-tolerated than clopidogrel in patients with PAD (EUCLID trial). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314204/all/Ticagrelor_no_more_effective_and_less_well_tolerated_than_clopidogrel_in_patients_with_PAD__EUCLID_trial_. Accessed March 27, 2023.
Ticagrelor no more effective and less well-tolerated than clopidogrel in patients with PAD (EUCLID trial). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314204/all/Ticagrelor_no_more_effective_and_less_well_tolerated_than_clopidogrel_in_patients_with_PAD__EUCLID_trial_
Ticagrelor No More Effective and Less Well-tolerated Than Clopidogrel in Patients With PAD (EUCLID Trial) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314204/all/Ticagrelor_no_more_effective_and_less_well_tolerated_than_clopidogrel_in_patients_with_PAD__EUCLID_trial_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ticagrelor no more effective and less well-tolerated than clopidogrel in patients with PAD (EUCLID trial)
ID - 1314204
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314204/all/Ticagrelor_no_more_effective_and_less_well_tolerated_than_clopidogrel_in_patients_with_PAD__EUCLID_trial_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
